Currently, the share price for Medicamen Organics Ltd. is delayed. Login to view live prices.
Medicamen Organics Ltd.
₹26.00
NSE
-- ( -- %) 1D
Income Statement
Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Operating Revenue | 25.27 | +14.09% |
| Other Income | 0.02 | -97.56% |
| Total Income | 25.29 | +10.15% |
| Total Expenditure | 21.90 | +1.39% |
| EBIDT | 4.76 | +77.61% |
| Depreciation | 0.72 | +1.41% |
| Interest | 0.65 | +6.56% |
| Tax | 0.98 | +151.28% |
| Net Profit | 2.40 | +147.42% |
Balance Sheet
A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Total Current Assets | 27.31 | +30.86% |
| Total Non-Current Assets | 11.27 | -3.84% |
| Fixed assets | 10.50 | -3.40% |
| Total assets | 38.58 | +18.38% |
| Total Current Liabilities | 21.84 | -0.27% |
| Total Non-Current Liabilities | 1.56 | -8.77% |
| Total Capital Plus Liabilities | 38.58 | +18.38% |
| Total Shareholder Funds | 15.18 | +69.04% |
| Total Debt to Equity | 0.83 | -36.64% |
Cash Flow
The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
| Particulars (In Cr) | Mar 2024 | Y/Y Change |
|---|---|---|
| Cash from Operating Activity | -3.69 | +536.21% |
| Cash from Financing Activities | 4.01 | +326.60% |
| Cash from Investing Activities | -0.33 | +17.86% |
| Net Cash Flow | -0.01 | -114.29% |
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer